Erratum (DOI:10.1053/j.ajkd.2009.03.010);Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination

American Journal of Kidney Diseases

Volumn 54, Issue 1, 2009, Pages 95-103

  Barraclough, Katherine A ^a   Wiggins, Kathryn J ^a   Hawley, Carmel M ^a   van Eps, Carolyn L ^a   Mudge, David W ^a   Johnson, David W ^a   Whitby, Michael ^b   Carpenter, Sally ^a   Playford, E Geoffrey ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

hemodialysis; Hepatitis B virus (HBV); intradermal (ID); vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; IMMUNITY; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; SEROCONVERSION; TREATMENT DURATION; TREATMENT RESPONSE; VACCINATION;

EID: 67449168123     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.06.018     Document Type: Erratum

References (45)

1. Tokars J.I., Finelli L., Alter M.J., and Arduino M.J. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 17 (2004) 310-319
2. Centers for Disease Control. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50 (2001) 1-43
3. Centers for Disease Control. Hepatitis: control measures for hepatitis B in dialysis centers (1977), US Department of Health, Education and Welfare, Public Health Services, CDC, Atlanta, GA HEW publication no. (CDC) 78-8358 (Viral Hepatitis Investigations and Control Series)
4. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee (AICP): Inactivated hepatitis B virus vaccine. MMWR Recomm Rep 31 (1982) 317-328
5. Schroth R.J., Hitchon C.A., Uhanova J., et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev (2004) CD003775
6. Centers for Disease Control. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination-recommendations of the Immunization Practices Advisory Committee (AICP). MMWR Recomm Rep 40 (1991) 1-24
7. Kausz A., and Pahari D. The value of vaccination in chronic kidney disease. Semin Dial 17 (2004) 9-11
8. DaRoza G., Loewen A., Djurdjev O., et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis 42 (2003) 1184-1192
9. Dukes C.S., Street A.C., Starling J.F., and Hamilton J.D. Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis. Vaccine 11 (1993) 1229-1232
10. Seaworth B., Drucker J., Starling J., Drucker R., Stevens C., and Hamilton J. Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis 157 (1988) 332-337
11. Waite N.M., Thomson L.G., and Goldstein M.B. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 5 (1995) 1930-1934
12. Rangel M.C., Coronado V.G., Euler G.L., and Strikas R.A. Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Semin Dial 13 (2000) 101-107
13. Chow K.M., Law M.C., Leung C.B., Szeto C.C., and Li P.K. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103 (2006) c89-c93
14. Rawer P., Willems W.R., Breidenbach T., Guttmann W., Pabst W., and Schutterle G. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation. Kidney Int Suppl 22 (1987) S149-S152
15. Tong N.K., Berab J., Kee S.A., et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis patients. Kidney Int 68 (2005) 2298-2303
16. Kong N.C., Berab J., Kee S.A., et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 73 (2008) 856-862
17. Donati D., and Gastaldi L. Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron 50 (1988) 133-136
18. Meuer S.C., Dumann H., Meyer zum Buschenfelde K.H., and Kohler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1 (1989) 15-18
19. Quiroga J.A., and Carreno V. Interferon and hepatitis B vaccine in haemodialysis patients. Lancet 1 (1989) 1264
20. Fabrizi F., Andrulli S., Bacchini G., Corti M., and Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 12 (1997) 1204-1211
21. Chang P.C., Schrander-van der Meer A.M., van Dorp W.T., and van Leer E. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients. Nephrol Dial Transplant 11 (1996) 191-193
22. Charest A.F., McDougall J., and Goldstein M.B. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36 (2000) 976-982
23. Miller K.D., Gibbs R.D., Mulligan M.M., Nutman T.B., and Francis D.P. Intradermal hepatitis B virus vaccine: Immunogenicity and side-effects in adults. Lancet 2 (1983) 1454-1456
24. Ono K., and Kashiwagi S. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients. Nephron 58 (1991) 47-51
25. Propst T., Propst A., Lhotta K., Vogel W., and Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 32 (1998) 1041-1045
26. Mettang T., Schenk U., Thomas S., et al. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study. Nephron 72 (1996) 192-196
27. Laurent P.E., Bonnet S., Alchas P., et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25 (2007) 8833-8842
28. Zuckerman A.J. Appraisal of intradermal immunisation against hepatitis B. Lancet 1 (1987) 435-436
29. Redfield R.R., Innis B.L., Scott R.M., Cannon H.G., and Bancroft W.H. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 254 (1985) 3203-3206
30. Coleman P.J., Shaw Jr. F.E., Serovich J., Hadler S.C., and Margolis H.S. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 9 (1991) 723-727
31. Gonzalez M.L., Usandizaga M., Alomar P., et al. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 8 (1990) 402-405
32. Lancaster D., Elam S., and Kaiser A.B. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine. Am J Infect Control 17 (1989) 126-129
33. Playford E.G., Hogan P.G., Bansal A.S., et al. Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol 23 (2002) 87-90
34. Vlassopoulos D., Arvanitis D., Lilis D., Hatjiyannakos D., Louizou K., and Hadjiconstantinou V. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Ren Fail 19 (1997) 455-460
35. Fabrizi F., Dixit V., Magnini M., Elli A., and Martin P. Meta-analysis: Intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 24 (2006) 497-506
36. Mast E.E., Margolis H.S., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Recomm Rep 54 (2005) 1-31
37. Mast E.E., Weinbaum C.M., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: Immunization of adults. MMWR Recomm Rep 55 (2006) 1-33 quiz, CE31-CE34
38. Micozkadioglu H., Zumrutdal A., Torun D., Sezer S., Ozdemir F.N., and Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 29 (2007) 285-288
39. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 355 (2000) 561-565
40. Laplanche A., Courouce A.M., Benhamou E., and Jungers P. Timing of hepatitis B revaccination in healthy adults. Lancet 1 (1987) 1206-1207
41. Buti M., Viladomiu L., Jardi R., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12 (1992) 144-147
42. Pasko M.T., Bartholomew W.R., Beam Jr. T.R., Amsterdam D., and Cunningham E.E. Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients. Am J Kidney Dis 11 (1988) 326-331
43. Stevens C., Taylor P.E., Tong M.J., Toy P.T., and Vyas G.N. Viral Hepatitis and Liver Disease (1984), Grune & Stratton, Orlando, FL
44. Hadler S.C., Coleman P.J., O'Malley P.M., Judson F.N., and Altman N.L. Evaluation of Long-term Protection by Hepatitis B Vaccine for Seven to Nine Years in Homosexual Men (1991), Williams & Wilkins, Baltimore, MD
45. Marangi A.L., Giordano R., Montanaro A., et al. Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 23 (1994) 537-542